financetom
Business
financetom
/
Business
/
--Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs
Jul 8, 2025 11:15 AM

01:47 PM EDT, 07/08/2025 (MT Newswires) --

Price: 25.49, Change: +0.25, Percent Change: +0.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Surpasses Fiscal First-Quarter Views; Affirms Full-Year Outlook
Broadcom Surpasses Fiscal First-Quarter Views; Affirms Full-Year Outlook
Mar 7, 2024
04:53 PM EST, 03/07/2024 (MT Newswires) -- Broadcom ( AVGO ) late Thursday reported stronger-than-expected fiscal first-quarter results as the chipmaker benefited from its VMware acquisition and artificial intelligence demand. Adjusted earnings rose to $10.99 a share during the quarter through Feb. 4 from $10.33 a year earlier, coming in ahead of the Capital IQ-polled consensus indicating $10.42. Revenue advanced...
Savers Value Village Adjusted EPS Lower, Sales Higher; Issues Outlook -- Shares Fall After-Hours
Savers Value Village Adjusted EPS Lower, Sales Higher; Issues Outlook -- Shares Fall After-Hours
Mar 7, 2024
04:53 PM EST, 03/07/2024 (MT Newswires) -- Savers Value Village ( SVV ) posted Q4 adjusted earnings late Thursday of $0.15 per diluted share, down from $0.18 a year ago. Analysts polled by Capital IQ expected $0.17. Net sales for the quarter ended Dec. 30 were $382.8 million, up from $366.8 million a year earlier. Analysts surveyed by Capital IQ...
United Therapeutics Insider Sold Shares Worth $1,424,309, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,424,309, According to a Recent SEC Filing
Mar 7, 2024
04:56 PM EST, 03/07/2024 (MT Newswires) -- Paul A Mahon, Executive Vice President & General Counsel, on March 07, 2024, sold 6,000 shares in United Therapeutics ( UTHR ) for $1,424,309. Following the Form 4 filing with the SEC, Mahon has control over a total of 36,599 shares of the company, with 36,599 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924007191/xslF345X03/form4-03072024_090331.xml Price:...
Target Insider Sold Shares Worth $993,620, According to a Recent SEC Filing
Target Insider Sold Shares Worth $993,620, According to a Recent SEC Filing
Mar 7, 2024
04:51 PM EST, 03/07/2024 (MT Newswires) -- Michael J Fiddelke, Executive Officer, on March 06, 2024, sold 5,750 shares in Target ( TGT ) for $993,620. Following the Form 4 filing with the SEC, Fiddelke has control over a total of 55,378 shares of the company, with 55,378 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/27419/000002741924000011/xslF345X03/wk-form4_1709847954.xml Price: 171.2, Change: -0.34, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved